# A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

> **NCT02502721** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 58 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWC20151
- **DRUG:** DWC20152

## Key facts

- **NCT ID:** NCT02502721
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2015-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02502721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02502721, "A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT02502721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*